切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - sodium channels - 5-HT7 Receptors - Squalene epoxidases

9 件产品

每页
清除全部
  1. β-Pompilidotoxin
    A1132 β-Pompilidotoxin
    Target: sodium channels
    Summary: 减慢Na+通道失活。
      ≥155.8 mg/mL
      ≥22.05 mg/mL
  2. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  3. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  4. Butenafine HCl
    B1901 Butenafine HCl
    中文名: 盐酸布替萘芬
    Target: Squalene epoxidases
    Summary: 合成苄胺抗真菌剂
      ≥17.55 mg/mL
      insoluble in H2O
  5. Terbinafine HCl
    B2047 Terbinafine HCl
    中文名: 盐酸特比萘芬
    Target: Squalene epoxidases
    Summary: 有效的非竞争性角鲨烯环氧酶抑制剂
      ≥16.3 mg/mL
      insoluble in H2O
  6. Terbinafine
    A8533 Terbinafine
    中文名: 特比萘芬
    Target: Squalene epoxidases
    Summary: 烯丙胺抗真菌剂
      ≥11.9 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. NB-598 hydrochloride
    A3646 NB-598 hydrochloride
    Target: Squalene epoxidases
    Summary: SE抑制剂
      ≥54 mg/mL
      insoluble in H2O
  9. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL

9 件产品

每页